Ravi Sodha speaks fluent pharma and business—with a PhD in Pharmacology and an MBA from Henley, he’s just as comfortable negotiating deals as he is interpreting data. After two decades at Novartis and another at Actelion, he knows the ins and outs of licensing like few others. Since 2018, he’s steered his own consultancy, helping biotech clients from Seoul to San Francisco raise funds, license assets, and close acquisitions. Ravi doesn’t just talk strategy—he makes it happen.  If there were a deal-making Olympics, Ravi would have earned a permanent podium spot.